7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-N-(2-methoxyethyl)-1-(pyridine-2-ylmethyl)-1H-imidazo[4,5-c]quinoline-2-amine

ID: ALA4874790

PubChem CID: 66571407

Max Phase: Preclinical

Molecular Formula: C25H26N6O3

Molecular Weight: 458.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COCCNc1nc2cnc3cc(-c4c(C)noc4C)c(OC)cc3c2n1Cc1ccccn1

Standard InChI:  InChI=1S/C25H26N6O3/c1-15-23(16(2)34-30-15)19-11-20-18(12-22(19)33-4)24-21(13-28-20)29-25(27-9-10-32-3)31(24)14-17-7-5-6-8-26-17/h5-8,11-13H,9-10,14H2,1-4H3,(H,27,29)

Standard InChI Key:  CUJZFENGTCXFNC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   13.7404   -5.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7392   -5.8899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4541   -6.3027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4523   -4.6498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1676   -5.0588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1684   -5.8858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8837   -6.2967    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5988   -5.8819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8781   -4.6447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5907   -5.0530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1992   -4.5015    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8626   -3.7523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0463   -3.8409    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4921   -3.2297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0258   -4.6502    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0256   -3.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0244   -6.3018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2737   -5.9690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7212   -6.5817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1332   -7.2965    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.9402   -7.1255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1019   -5.1621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5539   -7.6769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7444   -2.4442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5505   -2.2755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8030   -1.4908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2487   -0.8786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4386   -1.0564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1900   -1.8407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2727   -3.0364    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0977   -3.0335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5078   -2.3177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3328   -2.3149    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.7429   -1.5991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8 10  1  0
  9  5  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  1  0
 13 14  1  0
  1 15  1  0
 15 16  1  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 17  2  0
 18 22  1  0
 21 23  1  0
 14 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 12 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
M  END

Associated Targets(Human)

CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 458.52Molecular Weight (Monoisotopic): 458.2066AlogP: 4.37#Rotatable Bonds: 8
Polar Surface Area: 100.12Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.92CX LogP: 2.52CX LogD: 2.52
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.34Np Likeness Score: -1.45

References

1. Jones KL, Beaumont DM, Bernard SG, Bit RA, Campbell SP, Chung CW, Cutler L, Demont EH, Dennis K, Gordon L, Gray JR, Haase MV, Lewis AJ, McCleary S, Mitchell DJ, Moore SM, Parr N, Robb OJ, Smithers N, Soden PE, Suckling CJ, Taylor S, Walker AL, Watson RJ, Prinjha RK..  (2021)  Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression.,  64  (16.0): [PMID:34387088] [10.1021/acs.jmedchem.1c00855]

Source